Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus

Stroke. 1996 Aug;27(8):1316-8. doi: 10.1161/01.str.27.8.1316.

Abstract

Background and purpose: Our aim was to determine the predictive factors for stroke in patients with non-insulin-dependent diabetes mellitus (NIDDM).

Methods: We studied 133 patients with NIDDM at the time of diagnosis and 5 and 10 years later.

Results: The number of new fatal or nonfatal strokes was 19 (14.7%; 14 after 5-year examination). High initial fasting blood glucose (odds ratio [OR], 1.2; 95% confidence interval [CI], 1.04 to 1.4) and the use of beta-blocking agents (OR, 6.7; 95% CI, 2.1 to 21.5) at baseline and the presence of parasympathetic neuropathy (OR, 6.7; 95% CI, 1.5 to 29.9), or sympathetic autonomic nervous dysfunction (OR, 1.1; 95% CI, 1.01 to 1.2), hypertriglyceridemia (OR, 5.7; 95% CI, 1.1 to 31.0), or use of beta-blocking agents (OR, 6.4; 95% CI, 1.3 to 31.2), and high fasting plasma glucose (OR, 1.2; 95% CI, 1.0 to 1.5) determined at 5-year examination predicted the development of stroke.

Conclusions: Autonomic neuropathy is an independent risk factor for stroke in NIDDM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Autonomic Nervous System Diseases / complications*
  • Autonomic Nervous System Diseases / epidemiology
  • Blood Glucose
  • Body Constitution / physiology
  • Cerebrovascular Disorders / complications*
  • Cerebrovascular Disorders / epidemiology
  • Cholesterol / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetic Neuropathies / complications*
  • Diabetic Neuropathies / epidemiology
  • Electrocardiography
  • Female
  • Humans
  • Male
  • Predictive Value of Tests
  • Risk Factors
  • Sex Factors
  • Triglycerides / blood

Substances

  • Blood Glucose
  • Triglycerides
  • Cholesterol